Financial stability has deteriorated significantly, with the debt-to-equity ratio surging to 1.37 in 2026Q1 from 0.12 in 2023Q4, reflecting an increasing reliance on leverage.
| Total Current Assets | 95.81M | 99.08M | 99.41M | 148.05M | 196.25M | 282.86M | 109.69M | 33.76M |
| Cash & Short-Term Investments | 65.39M | 70.29M | 80.23M | 123.25M | 178.61M | 265.32M | 97.34M | 18.43M |
| Cash Only | 65.39M | 70.29M | 80.23M | 123.25M | 161.31M | 192.96M | 74.63M | 18.07M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 17.31M | 72.36M | 22.72M | 366K |
| Accounts Receivable | 14.31M | 18.53M | 8.69M | 15.21M | 8.05M | 7.09M | 7.85M | 9.71M |
| Days Sales Outstanding | 57.1 | 87.51 | 48.67 | 88.98 | 61.8 | 63.97 | 100.94 | 139.67 |
| Inventory | 7.09M | 6.35M | 5.87M | 6.48M | 5.16M | 5.73M | 3.38M | 3.61M |
| Days Inventory Outstanding | 90.47 | 78.69 | 100.86 | 121.59 | 115.41 | 137.31 | 115.34 | 174.94 |
| Other Current Assets | 9.02M | 758K | 835K | 345K | 731K | 775K | 27K | 339K |
| Total Non-Current Assets | 61.18M | 64.38M | 55.9M | 58.11M | 47.58M | 37.32M | 22.42M | 17.9M |
| Property, Plant & Equipment | 16.8M | 18.05M | 19.38M | 23.1M | 21.4M | 15.96M | 5.54M | 6.45M |
| Fixed Asset Turnover | 4.58x | 4.28x | 3.36x | 2.70x | 2.22x | 2.54x | 5.13x | 3.93x |
| Goodwill | 35.82M | 9.56M | 8.34M | 9M | 8.19M | 8.3M | 8.6M | 7.83M |
| Intangible Assets | 0 | 26.34M | 20.66M | 18.19M | 11.78M | 7.38M | 4.68M | 2.4M |
| Long-Term Investments | 1.98M | 1.98M | 0 | 0 | 0 | 0 | 775K | 373K |
| Other Non-Current Assets | 6.75M | 6.21M | 5.76M | 6.1M | 4.28M | 3.7M | 711K | 839K |
| Total Assets | 157M | 163.46M | 155.31M | 206.16M | 243.84M | 320.17M | 132.12M | 51.66M |
| Asset Turnover | 0.49x | 0.47x | 0.42x | 0.30x | 0.20x | 0.13x | 0.21x | 0.49x |
| Asset Growth % | 2.36% | 5.24% | -24.66% | -15.45% | -23.84% | 142.34% | 155.76% | - |
| Total Current Liabilities | 46.59M | 50.53M | 26.8M | 35.62M | 26.81M | 28.6M | 21.59M | 19.26M |
| Accounts Payable | 12.67M | 5.32M | 1.93M | 2.26M | 2.17M | 2.34M | 1.28M | 1.73M |
| Days Payables Outstanding | 121.67 | 65.86 | 33.21 | 42.32 | 48.57 | 56.01 | 43.66 | 83.79 |
| Short-Term Debt | 2.71M | 2.7M | 0 | 0 | 0 | 0 | 2.87M | 2.23M |
| Deferred Revenue (Current) | 42.31M | 16.72M | 5.73M | 9.49M | 3.43M | 4.07M | 2.64M | 2.1M |
| Other Current Liabilities | 15.27M | 5.32M | 11.22M | 13.58M | 10.27M | 9.16M | 5.25M | 5.73M |
| Current Ratio | 2.06x | 1.96x | 3.71x | 4.16x | 7.32x | 9.89x | 5.08x | 1.75x |
| Quick Ratio | 1.90x | 1.84x | 3.49x | 3.97x | 7.13x | 9.69x | 4.92x | 1.57x |
| Cash Conversion Cycle | 25.9 | 100.35 | 116.32 | 168.25 | 128.64 | 145.26 | 172.62 | 230.82 |
| Total Non-Current Liabilities | 64.71M | 65.78M | 32.02M | 19.09M | 16.9M | 16.17M | 10.02M | 10.14M |
| Long-Term Debt | 47.84M | 47.73M | 13.24M | 0 | 0 | 0 | 457K | 1.61M |
| Capital Lease Obligations | 51.5M | 12.59M | 14.6M | 15.67M | 14.05M | 11.25M | 2.88M | 3.66M |
| Deferred Tax Liabilities | 424K | 424K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 5M | 5.04M | 4.18M | 3.42M | 2.85M | 4.92M | 6.54M | 4.79M |
| Total Liabilities | 111.31M | 116.31M | 58.82M | 54.71M | 43.71M | 44.77M | 31.61M | 29.4M |
| Total Debt | 62.42M | 63.02M | 30.03M | 18.6M | 16.74M | 13.06M | 7.25M | 8.46M |
| Net Debt | -2.97M | -7.27M | -50.2M | -104.65M | -144.56M | -179.9M | -67.38M | -9.61M |
| Debt / Equity | 1.37x | 1.34x | 0.31x | 0.12x | 0.08x | 0.05x | 0.07x | 0.38x |
| Debt / EBITDA | -0.99x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 0.05x | - | - | - | - | - | - | - |
| Interest Coverage | -15.13x | -15.57x | -31.03x | -132.49x | -136.07x | -110.71x | -48.08x | -33.46x |
| Total Equity | 45.69M | 47.15M | 96.49M | 151.44M | 200.13M | 275.4M | 100.51M | 22.25M |
| Equity Growth % | -181.16% | -51.14% | -36.29% | -24.33% | -27.33% | 174% | 351.67% | - |
| Book Value per Share | 0.64 | 0.70 | 1.47 | 2.34 | 3.12 | 4.98 | 2.09 | 0.35 |
| Total Shareholders' Equity | 45.69M | 47.15M | 96.49M | 151.44M | 200.13M | 275.4M | 100.51M | 22.25M |
| Common Stock | 4.81M | 4.81M | 4.19M | 4.05M | 3.46M | 3.33M | 2.46M | 1.95M |
| Retained Earnings | -538.6M | -519.28M | -440.28M | -377.78M | -298.8M | -211.35M | -137.68M | -98.34M |
| Treasury Stock | -1.01M | -1.22M | -702K | -646K | -117K | 0 | 0 | 0 |
| Accumulated OCI | 92.06M | 89.15M | 61.04M | 53.98M | 23.96M | 12.54M | 8.3M | -581K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Insufficient liquidity for operations
As reported in recent financial statements, SOPH's equity base has contracted from $151.4M in 2023Q4 to $45.7M in 2026Q1, reflecting a persistent trend of capital erosion driven by cumulative losses that significantly impair the company's long-term balance sheet stability and overall financial health.
The consistent decline in equity, coupled with a widening deficit in retained earnings, suggests that the company is struggling to reach a self-sustaining scale. Investors should monitor whether this trajectory necessitates further dilutive financing to maintain operations, as the current pace of capital consumption appears unsustainable.
Based on the provided balance sheet data, SOPH's debt-to-equity ratio has surged from 0.12 in 2023Q4 to 1.37 in 2026Q1, indicating that the firm is increasingly relying on debt financing to bridge the gap between its operating cash burn and its strategic growth objectives.
This rapid shift toward higher leverage in a loss-making environment suggests a heightened risk profile, particularly if the company fails to generate positive cash flow to service these obligations. The reliance on debt to fund operations may limit future financial flexibility and increase sensitivity to interest rate fluctuations.
According to recent SEC filings, SOPH's cash position has declined to $65.4M as of 2026Q1, which, when measured against the company's ongoing operating losses, suggests a tightening liquidity buffer that warrants close investigation regarding the firm's ability to fund its near-term operational requirements.
While the current ratio of 2.06 appears superficially adequate, the underlying cash burn rate indicates that the company's runway is rapidly diminishing. This liquidity profile suggests that management may face significant pressure to secure additional capital or drastically reduce expenditures to avoid a potential funding shortfall.
As evidenced by the quarterly balance sheet data, SOPH's goodwill has fluctuated significantly, jumping from $9.6M in 2025Q4 to $35.8M in 2026Q1, which may indicate recent acquisition activity that potentially obscures the underlying quality and tangible value of the company's asset base.
The sudden increase in intangible assets warrants further investigation, as it may suggest that the company is attempting to bolster its asset side through inorganic growth rather than organic platform expansion. Investors should be cautious, as such volatility in goodwill can often precede impairment risks if the acquired assets fail to deliver expected synergies.
Quick answers to the most common questions about buying SOPH stock.
As of 2025, SOPHiA GENETICS S.A. (SOPH) had total assets of $163.5M including $99.1M in current assets.
SOPHiA GENETICS S.A. (SOPH) carries total debt of $63.0M, offset by $70.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
SOPHiA GENETICS S.A. (SOPH) has total shareholders' equity (book value) of $47.1M ($0.70 book value per share). Book value represents the net worth of the company belonging to common stock holders.
SOPHiA GENETICS S.A. (SOPH) reported a current ratio of 1.96x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.